Principal Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
7,026
+204
+3% +$53.6K 0.02% 550
2026
Q1
$1.82M Sell
6,822
-278
-4% -$75.3K 0.03% 529
2025
Q4
$1.78M Buy
7,100
+1,053
+17% +$280K 0.03% 519
2025
Q3
$1.74M Sell
6,047
-91
-1% -$24.4K 0.03% 493
2025
Q2
$1.61M Buy
6,138
+814
+15% +$198K 0.03% 477
2025
Q1
$1.22M Hold
5,324
0.03% 483
2024
Q4
$1.22M Buy
5,324
+421
+9% +$96.6K 0.03% 481
2024
Q3
$1.1M Buy
4,903
+200
+4% +$44K 0.03% 499
2024
Q2
$957K Buy
4,703
+534
+13% +$109K 0.03% 489
2024
Q1
$911K Sell
4,169
-1,136
-21% -$250K 0.03% 483
2023
Q4
$1.21M Buy
+5,305
New +$1.11M 0.04% 361

Other funds holding LH

Principal Securities's LH Position: Q2 2026 in Review

Principal Securities increased its Labcorp (LH) stake by 3% in Q2 2026, buying an estimated $53.6K and bringing the position to 7,026 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #550.

Principal Securities first reported a position in LH in Q4 2023 and has held it in 11 quarters since. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Principal Securities held 7,026 shares of Labcorp worth $1.97M as of Q2 2026.
  • Principal Securities bought 204 Labcorp shares in Q2 2026, an estimated $53.6K.
  • Labcorp made up 0.02% of Principal Securities's portfolio in Q2 2026, its #550 holding.
  • Principal Securities first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.